ADC Therapeutics

ZYNLONTA

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / ZYNLONTA – J9359

Manufacturer:

ADC Therapeutics

Name:

ZYNLONTA

HCPCS Code Descriptor:

Injection, loncastuximab tesirine-lpyl, 0.075 mg

Category:

J Code

HCPCS:

J9359

NDC(s):

79952-0110-01

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

ZYNLONTA is an Oncology drug manufactured by ADC Therapeutics and administered via the Intravenous route of administration. The J Code: J9359 is aligned to the drug ZYNLONTA.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

4/1/22

HCPCS Effective Date:

4/1/22

HCPCS Short Description:

Inj lon tesirin-lpyl 0.075mg

Billing and Coding Guide:

https://www.zynlontahcp.com/wp-content/uploads/2022/03/Coding-and-Billing-Guide-Download-30822.pdf

Patient Assistance:

https://www.advancingpatientsupport.com/hcp/#enroll-your-patient-now